Multiple molecular and genetic mechanisms influence the progression of MASLD in individuals with T2DM, including hepatic IR, lipotoxicity, oxidative stress, and inflammatory pathways mediated by adipokines and cytokines (e.g., TNF-α, IL-6). The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.